Accordingly, one rational therapeutic strategy for autoimmune hypophysitis is to block dendritic cell-T cell interaction in the pituitary by CTLA-4Ig (a fusion protein of the extracellular domain of CTLA-4 and an Fc fragment of IgG), given that our data show that T cells are activated in the pituitary. Here, CTLA4 is linked to primary hypophysitis.